Over the past 12 months, 5 insiders at Relay Therapeutics, Inc. filed 31 open-market SEC Form 4 transactions on RLAY: 0 purchases worth $0 and 31 sales worth $10.0M. Insiders have been net sellers over this period. The most recent filing was on Jul 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | Sanjiv PatelPresident and CEO | SELL | 48.2K | $19.58 | $944K |
| Jul 6, 26 | Donald A BergstromPresident, R&D | SELL | 8.7K | $18.71 | $162K |
| Jul 6, 26 | Thomas CatinazzoChief Financial Officer | SELL | 17.7K | $18.69 | $331K |
| Jun 30, 26 | Peter RahmerSee remarks | SELL | 50.0K | $19.09 | $955K |
| Jun 22, 26 | Donald A BergstromPresident, R&D | SELL | 93.5K | $16.94 | $1.6M |
| Jun 22, 26 | Thomas CatinazzoChief Financial Officer | SELL | 61.6K | $17.01 | $1.0M |
| May 14, 26 | Thomas CatinazzoChief Financial Officer | SELL | 17.7K | $12.86 | $228K |
| Apr 28, 26 | Donald A BergstromPresident, R&D | SELL | 1.5K | $14.79 | $22K |
| Apr 28, 26 | Thomas CatinazzoChief Financial Officer | SELL | 972 | $14.79 | $14K |
| Apr 9, 26 | Thomas CatinazzoChief Financial Officer | SELL | 1.8K | $15.00 | $27K |
| Apr 7, 26 | Thomas CatinazzoChief Financial Officer | SELL | 17.7K | $13.01 | $230K |
| Mar 9, 26 | Thomas CatinazzoChief Financial Officer | SELL | 17.7K | $10.06 | $178K |
| Jan 28, 26 | Donald A BergstromPresident, R&D | SELL | 2.7K | $8.45 | $23K |
| Jan 28, 26 | Thomas CatinazzoChief Financial Officer | SELL | 1.7K | $8.45 | $14K |
| Jan 28, 26 | Peter RahmerSee remarks | SELL | 1.4K | $8.45 | $11K |
| Jan 27, 26 | Donald A BergstromPresident, R&D | SELL | 18.9K | $7.62 | $144K |
| Jan 27, 26 | Thomas CatinazzoChief Financial Officer | SELL | 13.8K | $7.62 | $105K |
| Jan 27, 26 | Peter RahmerSee remarks | SELL | 11.7K | $7.62 | $89K |
| Jan 6, 26 | Sanjiv PatelPresident and CEO | SELL | 43.2K | $7.82 | $338K |
| Nov 3, 25 | Sanjiv PatelPresident and CEO | SELL | 62.1K | $7.00 | $435K |
| Oct 29, 25 | Peter RahmerSee remarks | SELL | 21.4K | $7.50 | $160K |
| Oct 28, 25 | Donald A BergstromPresident, R&D | SELL | 30.9K | $7.29 | $225K |
| Oct 28, 25 | Thomas CatinazzoChief Financial Officer | SELL | 21.7K | $7.29 | $158K |
| Oct 28, 25 | Peter RahmerSee remarks | SELL | 19.1K | $7.29 | $139K |
| Jul 29, 25 | Brian AdamsChief Legal Officer | SELL | 18.3K | $3.68 | $67K |
| Jul 29, 25 | Donald A BergstromPresident, R&D | SELL | 26.7K | $3.68 | $98K |
| Jul 29, 25 | Thomas CatinazzoChief Financial Officer | SELL | 18.4K | $3.68 | $68K |
| Jul 29, 25 | Peter RahmerSee remarks | SELL | 15.7K | $3.68 | $58K |
| Jul 28, 25 | Brian AdamsChief Legal Officer | SELL | 1.6K | $3.74 | $6K |
| Jul 28, 25 | Donald A BergstromPresident, R&D | SELL | 4.1K | $3.74 | $15K |
| Jul 28, 25 | Thomas CatinazzoChief Financial Officer | SELL | 1.7K | $3.74 | $6K |
| Jul 28, 25 | Peter RahmerSee remarks | SELL | 1.4K | $3.74 | $5K |
| Jul 9, 25 | Sanjiv PatelPresident and CEO | SELL | 42.7K | $3.57 | $153K |
| Apr 30, 25 | Brian AdamsChief Legal Officer | SELL | 12.9K | $3.00 | $39K |
| Apr 30, 25 | Donald A BergstromPresident, R&D | SELL | 27.5K | $3.00 | $82K |
| Apr 30, 25 | Thomas CatinazzoChief Financial Officer | SELL | 12.9K | $3.00 | $39K |
| Apr 30, 25 | Peter RahmerSee remarks | SELL | 10.7K | $3.00 | $32K |
| Apr 29, 25 | Thomas CatinazzoChief Financial Officer | SELL | 3.6K | $3.23 | $11K |
| Apr 28, 25 | Brian AdamsChief Legal Officer | SELL | 1.6K | $3.17 | $5K |
| Apr 28, 25 | Donald A BergstromPresident, R&D | SELL | 4.1K | $3.17 | $13K |
| Apr 28, 25 | Thomas CatinazzoChief Financial Officer | SELL | 1.7K | $3.17 | $5K |
| Apr 28, 25 | Peter RahmerSee remarks | SELL | 1.4K | $3.17 | $4K |
| Apr 23, 25 | Sanjiv PatelPresident and CEO | SELL | 42.8K | $2.97 | $127K |
| Mar 27, 25 | Brian AdamsChief Legal Officer | SELL | 298 | $2.84 | $846 |
| Mar 27, 25 | Donald A BergstromPresident, R&D | SELL | 986 | $2.84 | $3K |
| Mar 27, 25 | Thomas CatinazzoChief Financial Officer | SELL | 4.6K | $2.84 | $13K |
| Mar 27, 25 | Peter RahmerSee remarks | SELL | 247 | $2.84 | $701 |
| Feb 13, 25 | Sanjiv PatelPresident and CEO | SELL | 75.3K | $3.70 | $279K |
| Feb 11, 25 | Sanjiv PatelPresident and CEO | SELL | 140.2K | $3.85 | $540K |
| Jan 30, 25 | Brian AdamsChief Legal Officer | SELL | 20.8K | $4.42 | $92K |
Over the past 12 months, insiders at Relay Therapeutics, Inc. filed 0 open-market purchases worth $0 and 31 sales worth $10.0M on RLAY, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 7, 26.
5 different insiders at Relay Therapeutics, Inc. filed open-market SEC Form 4 transactions on RLAY over the last 12 months.
InsiderTape plots every RLAY insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Relay Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →